Company Search:
Advanced Search
Sponsored Links
Rigel Pharmaceuticals, Inc. Company Snapshot
Rigel Pharmaceuticals, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Rigel Pharmaceuticals with three other companies in this sector in UNITED STATES : Palatin Technologies, Inc. (2019 sales of $60.30 million of which 100% was Licenses, Grants and Contracts), Avadel Pharmaceuticals PLC ($59.21 million of which 100% was PHARMACEUTICAL PREPARATIONS), and Pliant Therapeutics Inc ($57.05 million of which 100% was PHARMACEUTICAL).

Sales Analysis. Rigel Pharmaceuticals reported sales of $59.29 million for the year ending December of 2019. This represents an increase of 33.2% versus 2018, when the company's sales were $44.51 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Rigel Pharmaceuticals, Inc.
  Stock Performance Chart for Rigel Pharmaceuticals, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 2.27
(Figures in U.S. Dollars)
1 Week -10.6%   13 Weeks -7.0%  
4 Weeks 23.4%   52 Weeks 24.0%  
Rigel Pharmaceuticals, Inc. Key Data:
  Ticker: RIGL Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 59,288,000
(Year Ending Jan 2020).
Employees: 163
  Currency: U.S. Dollars Market Cap: 383,443,004
  Fiscal Yr Ends: December Shares Outstanding: 168,917,623
  Share Type: Common Closely Held Shares: 520,984
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.